PAPAVERINE HCL
VASODILATORS·CEREBRAL ISCHEMIA·+1
American Regent
Indication
Cerebral ischemia
Cerebral ischemia is a critical condition characterized by insufficient blood flow to the brain, failing to supply adequate oxygen and glucose to meet metabolic demands. Read more about Cerebral ischemia
4 drugs 4 manufacturers
Drugs that treat it
Common Cerebral ischemia therapies.
PAPAVERINE HCL
VASODILATORS·CEREBRAL ISCHEMIA·+1
NEXUS PHARMACEU
PAPAVERINE HCL
VASODILATORS·CEREBRAL ISCHEMIA·+1
BPI LABS, LLC
PAPAVERINE HCL
VASODILATORS·CEREBRAL ISCHEMIA·+1
ORYZA PHARMACEU
Filter & compare in the drug finder →Opens the drug finder with Cerebral ischemia preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCerebral ischemia is a critical condition characterized by insufficient blood flow to the brain, failing to supply adequate oxygen and glucose to meet metabolic demands.
Primarily affecting the central nervous system, it can present globally due to systemic circulatory collapse or focally following localized arterial occlusion, thrombosis, or embolism.
Cellular energy failure, loss of ionic gradients, excitotoxicity, and microvascular compromise define its underlying pathophysiology.
Clinically, these disruptions manifest as acute focal neurological deficits, altered consciousness, or cognitive dysfunction, which may resolve transiently or advance to irreversible neuronal death and cerebral infarction if hypoperfusion persists.
- nih.gov
Cerebral ischemia is a critical condition characterized by insufficient blood flow to the brain, failing to supply adequate oxygen and glucose to meet metabolic demands
- nih.gov
Cerebral ischemia is a critical condition characterized by insufficient blood flow to the brain, failing to supply adequate oxygen and glucose to meet metabolic demands
- nih.gov
Primarily affecting the central nervous system, it can present globally due to systemic circulatory collapse or focally following localized arterial occlusion, thrombosis, or embolism
- columbia.edu
Primarily affecting the central nervous system, it can present globally due to systemic circulatory collapse or focally following localized arterial occlusion, thrombosis, or embolism
- youtube.com
Primarily affecting the central nervous system, it can present globally due to systemic circulatory collapse or focally following localized arterial occlusion, thrombosis, or embolism Clinically, these disruptions manifest as acute focal neurological deficits, altered consciousness, or cognitive dysfunction, which may resolve transiently or advance to irreversible neuronal death and cerebral infarction if hypoperfusion persists
- nih.gov
Cellular energy failure, loss of ionic gradients, excitotoxicity, and microvascular compromise define its underlying pathophysiology
- nih.gov
Cellular energy failure, loss of ionic gradients, excitotoxicity, and microvascular compromise define its underlying pathophysiology
- nih.gov
Clinically, these disruptions manifest as acute focal neurological deficits, altered consciousness, or cognitive dysfunction, which may resolve transiently or advance to irreversible neuronal death and cerebral infarction if hypoperfusion persists
- nih.gov
Clinically, these disruptions manifest as acute focal neurological deficits, altered consciousness, or cognitive dysfunction, which may resolve transiently or advance to irreversible neuronal death and cerebral infarction if hypoperfusion persists
- nih.gov
Clinically, these disruptions manifest as acute focal neurological deficits, altered consciousness, or cognitive dysfunction, which may resolve transiently or advance to irreversible neuronal death and cerebral infarction if hypoperfusion persists
Personalize your experience
Follow Cerebral ischemia and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.